SEARCH

SEARCH BY CITATION

References

  • Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y. & Martelli, M.F. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New England Journal of Medicine, 339, 11861193.
  • Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. & Fibbe, W.E. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110, 27642767.
  • Ballen, K.K., Spitzer, T.R., Yeap, B.Y., McAfee, S., Dey, B.R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, R. & Antin, J.H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biology of Blood and Marrow Transplantation, 13, 8289.
  • Barker, J.N., Krepski, T.P., DeFor, T.E., Davies, S.M., Wagner, J.E. & Weisdorf, D.J. (2002) Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biology of Blood and Marrow Transplantation, 8, 257260.
  • Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B. & Wagner, J.E. (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 13431347.
  • Bautista, G., Cabrera, J.R., Regidor, C., Forés, R., Garcıa-Marco, J.A., Ojeda, E., Sanjuán, I., Ruiz, E., Krsnik, I., Navarro, B., Gil, S., Magro, E., De Laiglesia, A., Gonzalo-Daganz, R., Martın-Donaire, T., Rico, M., Millán, I. & Fernandez, M.N. (2009) Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplantation, 43, 365373.
  • Beziat, V., Nguyen, S., Lapusan, S., Hervier, B., Dhedin, N., Bories, D., Uzunov, M., Boudifa, A., Trebeden-Negre, H., Norol, F., Marjanovic, Z., Marie, J.P., Vernant, J.P., Debre, P., Rio, B. & Vieillard, V. (2009) Fully functional NK cells after unrelated cord blood transplantation. Leukemia, 23, 721728.
  • Broxmeyer, H.E., Douglas, G.W., Hangoc, G., Cooper, S., Bard, J., English, D., Arny, M., Thomas, L. & Boyse, E.A. (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proceedings of the National Academy of Sciences of the USA, 86, 38283832.
  • Brunstein, C.G., Setubal, D.C. & Wagner, J.E. (2007a) Expanding the role of umbilical cord blood transplantation. British Journal of Haematology, 137, 2035.
  • Brunstein, C.G., Barker, J.N., Weisdorf, D.J., DeFor, T.E., Miller, J.S. & Wagner, J.E. (2007b) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 30643070.
  • Chen, Y.B. & Spitzer, T.R. (2008) Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors. Leukemia, 22, 3141.
  • Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., Olavarria, E., Goldman, J., Chakraverty, R., Mahendra, P., Craddock, C. & Moss, P.A. (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. The Journal of Experimental Medicine, 202, 379386.
  • Cohen, G., Carter, S.L., Weinberg, K.I., Masinsin, B., Guinan, E., Kurtzberg, J., Wagner, J.E., Kernan, N.A. & Parkman, R. (2006) Antigen-specific T-lymphocyte function after cord blood transplantation. Biology of Blood and Marrow Transplantation, 12, 13351342.
  • Comoli, P., Ginevri, F., Maccario, R., Frasson, C., Valente, U., Basso, S., Labirio, M., Huang, G.C., Verrina, E., Baldanti, F., Perfumo, F. & Locatelli, F. (2006) Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children. American Journal of Transplantation, 6, 21692176.
  • Comoli, P., Basso, S., Zecca, M., Pagliara, D., Baldanti, F., Bernardo, M.E., Barber, W., Moretta, A., Labirio, M., Paulli, M., Furione, M., Maccario, R. & Locatelli, F. (2007) Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. American Journal of Transplantation, 7, 16481655.
  • D’Arena, G., Musto, P., Cascavilla, N., Di Giorgio, G., Fusilli, S., Zendoli, F. & Carotenuto, M. (1998) Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica, 83, 197203.
  • Dallas, M., Delaney, C. & Bernstein, I. (2008a) Enhanced T cell reconstitution by cord blood progenitors expanded ex-vivo using the Notch ligand delta1. Blood (ASH Annual Meeting Abstracts), 112, 3497.
  • Dallas, M., Delaney, C., Varnum-Finney, B. & Bernstein, I. (2008b) Facilitation of thymic and bone marrow engraftment by hematopoietic progenitors expanded ex-vivo using the Notch ligand delta1. Blood (ASH Annual Meeting Abstracts), 112, 3498.
  • Delaney, C., Brashem-Stein, C., Voorhies, H., Gutman, J., Dallas, M., Heimfeld, S. & Bernstein, I. (2008) Notch-mediated expansion of human cord blood progenitor cells results in rapid myeloid reconstitution in vivo following myeloablative cord blood transplantation. Blood (ASH Annual Meeting Abstracts), 112, 212.
  • Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. & Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 19471954.
  • Einsele, H., Rauser, G., Grigoleit, U., Hebart, H., Sinzger, C., Riegler, S. & Jahn, G. (2002a) Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Cytotherapy, 4, 4954.
  • Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U., Moris, A., Rammensee, H.G., Kanz, L., Kleihauer, A., Frank, F., Jahn, G. & Hebart, H. (2002b) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 39163922.
  • Fernández, M.N., Grañena, A., Millán, I., Regidor, C., Cabrera, R., Querol, S. & García, J. (2000) Evaluation of engraftment of ex vivo expanded cord blood cells in humans. Bone Marrow Transplantation, 25 (Suppl. 2), S61S67.
  • Fernández, M.N., Regidor, C., Cabrera, R., García-Marco, J., Briz, M., Forés, R., Sanjuán, I., McWhinnie, A., Querol, S., García, J. & Madrigal, A. (2001) Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplantation, 28, 355363.
  • Fernández, M.N., Regidor, C., Cabrera, R., García-Marco, J.A., Forés, R., Sanjuán, I., Gayoso, J., Gil, S., Ruíz, E., Little, A.M., McWhinnie, A. & Madrigal, A. (2003) Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Experimental Hematology, 31, 535544.
  • Feuchtinger, T., Lang, P., Hamprecht, K., Schumm, M., Greil, J., Jahn, G., Niethammer, D. & Einsele, H. (2004) Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Experimental Hematology, 32, 282289.
  • Feuchtinger, T., Lucke, J., Hamprecht, K., Richard, C., Handgretinger, R., Schumm, M., Greil, J., Bock, T., Niethammer, D. & Lang, P. (2005) Detection of adenovirusspecific T cells in children with adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 128, 503509.
  • Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 6476.
  • Figueroa-Tentori, D., Querol, S., Dodi, I.A., Madrigal, A. & Duggleby, R. (2008) High purity and yield of natural Tregs from cord blood using a single step selection method. Journal of Immunological Methods, 31, 339.
  • Friedlander, M., Dorrell, M.I., Ritter, M.R., Marchetti, V., Moreno, S.K., El-Kalay, M., Bird, A.C., Banin, E. & Aguilar, E. (2007) Progenitor cells and retinal angiogenesis. Angiogenesis, 10, 89101.
  • Gill, J., Malin, M., Sutherland, J., Gray, D., Hollander, G. & Boyd, R. (2003) Thymic generation and regeneration. Immunological Reviews, 195, 2850.
  • Gluckman, E., Broxmeyer, H.A., Auerbach, A.D., Friedman, H.S., Douglas, G.W., Devergie, A., Esperou, H., Thierry, D., Socie, G. & Lehn, P. (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine, 321, 11741178.
  • Goldberg, J.L., Laughlin, M.J. & Pompili, V.J. (2007) Umbilical cord blood stem cells: implications for cardiovascular regenerative medicine. Journal of Molecular and Cellular Cardiology, 42, 912920.
  • Gonzalo-Daganzo, R., Regidor, C., Martín-Donaire, T., Rico, M.A., Bautista, B., Krsnik, I., Forés, R., Ojeda E, Sanjuán., I, García.-Marco.J.A., Navarro, B., Gil, S., Sánchez, R., Panadero, P., Gutiérrez, Y., García-Berciano, M., Pérez, N., Millán, I., Cabrera, R. & Fernández, M.N. (2009) Effects of Third Party Donor Mesenchymal Stem Cells in Cord Blood Transplantation in Adults. Results of a Pilot Study. Cytotherapy, 11, 278288.
  • Gottschalk, S., Bollard, C.M., Straathof, K.C., Louis, C.U., Savoldo, B., Dotti, G., Brenner, M.K., Heslop, H.E. & Rooney, C.M. (2006) T cell therapies. Ernst Schering Foundation Symposium Proceedings, 2006, 6982.
  • Greiner, J., Döhner, H. & Schmitt, M. (2006) Cancer vaccines for patients with acute myeloid leukemia – definition of leukemia-associated antigens and current clinical protocols targeting these antigens. Haematologica, 91, 16531661.
  • Grzywacz, B., Miller, J.S. & Verneris, M.R. (2008) Use of natural killer cells as immunotherapy for leukaemia. Best Practice & Research. Clinical Haematology, 21, 467483.
  • Güenechea, G., Segovia, J.C., Albella, B., Lamana, M., Ramírez, M., Regidor, C., Fernandez, M.N. & Bueren, J.A. (1999) Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood, 93, 10971105.
  • Gustafsson, A., Levitsky, V., Zou, J.Z., Frisan, T., Dalianis, T., Ljungman, P., Ringden, O., Winiarski, J., Ernberg, I. & Masucci, M.G. (2000) Epstein–Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood, 95, 807814.
  • Harris, D.T. 2008 Cord blood stem cells: a review of potential neurological applications (2008). Stem Cell Reviews, 4, 269274.
  • Heemskerk, M.H., Griffioen, M. & Falkenburg, J.H. (2008) T-cell receptor gene transfer for treatment of leukemia. Cytotherapy, 10, 108115.
  • Hoffmann, P., Eder, R., Kunz-Schughart, L.A., Andreesen, R. & Edinger, M. (2004) Largescale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood, 104, 895903.
  • Hwang, W.Y., Samuel, M., Tan, D., Koh, L.P., Lim, W. & Linn, Y.C. (2007) A meta-analysis of unrelated donor umbilical cord bloodtransplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biology of Blood and Marrow Transplantation, 13, 444453.
  • Jaroscak, J., Goltry, K., Smith, A., Waters-Pick, B., Martin, P.L., Driscoll, T.A., Howrey, R., Chao, N., Douville, J., Burhop, S., Fu, P. & Kurtzberg, J. (2003) Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aastrom Replicell System. Blood, 101, 50615067.
  • Junge, S., Kloeckener-Gruissem, B., Zufferey, R., Keisker, A., Salgo, B., Fauchere, J.C., Scherer, F., Shalaby, T., Grotzer, M., Siler, U., Seger, R. & Güngör, T. (2007) Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. European Journal of Immunology, 37, 32703280.
  • Kennedy-Nasser, A.A. & Brenner, M.K. (2007) T-cell therapy after hematopoietic stem cell transplantation. Current Opinion in Hematology, 14, 616624.
  • Kilpatrick, R.D., Rickabaugh, T., Hultin, L.E., Hultin, P., Hausner, M.A., Detels, R., Phair, J. & Jamieson, B.D. (2008) Homeostasis of the naïve CD4+ T cell compartment during aging. Journal of Immunology, 180, 14991507.
  • Kögler, G., Nürnberger, W., Fischer, J., Niehues, T., Somville, T., Göbel, U. & Wernet, P. (1999) Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplantation, 24, 397403.
  • Komanduri, K.V., St John, L.S., De Lima, M., McMannis, J., Rosinski, S., McNiece, I., Bryan, S.G., Kaur, I., Martin, S., Wieder, E.D., Worth, L., Cooper, L.J., Petropoulos, D., Molldrem, J.J., Champlin, R.E. & Shpall, E.J. (2007) Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood, 110, 45434551.
  • Kurtzberg, J., Prasad, V.K., Carter, S.L., Wagner, J.E., Baxter-Lowe, L.A., Wall, D., Kapoor, N., Guinan, E.C., Feig, S.A., Wagner, E.L. & Kernan, N.A.; COBLT Steering Committee. (2008) Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112, 43184327. Epub 2008 Aug 21 .
  • Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., Van Rood, J.J., Scaradavou, A. & Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New England Journal of Medicine, 351, 22652275.
  • Lazarus, H.M., Koc, O.N., Devine, S.M., Curtin, P., Maziarz, R.T., Holland, H.K., Shpall, E.J., McCarthy, P., Atkinson, K., Cooper, B.W., Gerson, S.L., Laughlin, M.J., Loberiza, Jr, F.R., Moseley, A.B. & Bacigalupo, A. (2005) Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biology of Blood and Marrow Transplantation, 11, 389398.
  • Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M. & Ringdén, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363, 14111412.
  • Le Blanc, K., Samuelsson, H., Gustafsson, B., Remberger, M., Sundberg, B., Arvidson, J., Ljungman, P., Lönnies, H., Nava, S. & Ringdén, O. (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia, 21, 17331738.
  • Leen, A.M. & Heslop, H.E. (2008) Cytotoxic T lymphocytes as immune-therapy in haematological practice. British Journal of Haematology, 143, 169179.
  • De Lima, M., McMannis, J., Gee, A., Komanduri, K., Couriel, D., Andersson, B.S., Hosing, C., Khouri, I., Jones, R., Champlin, R., Karandish, S., Sadeghi, T., Peled, T., Grynspan, F., Daniely, Y., Nagler, A. & Shpall, E.J. (2008) Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplantation, 41, 771778.
  • Magro, E., Regidor, C., Cabrera, R., Sanjuán, I., Forès, R., Garcia-Marco, J.A., Ruiz, E., Gil, S., Bautista, G., Millán, I., Madrigal, A. & Fernandez, M.N. (2006) Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Haematologica, 91, 640648.
  • Majhail, N.S., Brunstein, C.G., Tomblyn, M., Thomas, A.J., Wagner, J.E. & Weisdorf, D.J. (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation, 14, 282929.
  • Martín-Donaire, T., Rico, M., Bautista, G., Gonzalo-Daganzo, R., Regidor, C., Ojeda, E., Sanjuán, I., Forés, R., Ruiz, E., Krsnik, I., Navarro, B., Gil, S., Magro, E., Millán, I., Sánchez, R., Pérez-Sanz, N., Panadero, N., García-Marco, J.A., Cabrera, R. & Fernbández, M.N. (2009) Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplantation, doi:DOI: 10.1038/bmt.2009.15.
  • Merlo, A., Turrini, R., Dolcetti, R., Zanovello, P., Amadori, A. & Rosato, A. (2008) Adoptive cell therapy against EBV-related malignancies: a survey of clinical results. Expert Opinion on Biological Therapy, 8, 12651294.
  • Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K. & Gottlieb, D. (2007) Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 707714.
  • Mommaas, B., Stegehuis-Kamp, J.A., Van Halteren, A.G., Kester, M., Enczmann, J., Wernet, P., Kögler, G., Mutis, T., Brand, A. & Goulmy, E. (2005) Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood, 105, 18231827.
  • Moretta, A., Maccario, R., Fagioli, F., Giraldi, E., Busca, A., Montagna, D., Miniero, R., Comoli, P., Giorgiani, G., Zecca, M., Pagani, S. & Locatelli, F. (2001) Analysis of immune reconstitution in children undergoing cord blood transplantation. Experimental Hematology, 29, 371379.
  • Ning, H., Yang, F., Jiang, M., Hu, L., Feng, K., Zhang, J., Yu, Z., Li, B., Xu, C., Li, Y., Wang, J., Hu, J., Lou, X. & Chen, H. (2008) The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia, 22, 593599.
  • O’Reilly, R.J., Doubrovina, E., Trivedi, D., Hasan, A., Kollen, W. & Koehne, G. (2007) Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunologic Research, 38, 237250.
  • Park, K.D., Marti, L., Kurtzberg, J. & Szabolcs, P. (2006) In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. Blood, 108, 17701773.
  • Park, D.H., Borlongan, C.V., Eve, D.J. & Sanberg, P.R. (2008) The emerging field of cell and tissue engineering. Medical Science Monitor, 14, RA206RA220.
  • Parkman, R. (2008) Antigen specific immunituy following hematopoietic stem cell transplantation. Blood Cells, Molecules, and Diseases, 40, 9193.
  • Parkman, R., Cohen, G., Carter, S.L., Weinberg, K.I., Masinsin, B., Guinan, E., Kurtzberg, J., Wagner, J.E. & Kernan, N.A. (2006) Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 12, 919927.
  • Payne, T.A., Traycoff, C.M., Laver, J., Xu, F., Srour, E.F. & Abboud, M.R. (1995) Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Bone Marrow Transplantation, 15, 187189.
  • Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Guiver, M., Mos, P.A. & MacKinnon, S. (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 13751377.
  • Prasad, V.K., Mendizabal, A., Parikh, S.H., Szabolcs, P., Driscoll, T.A., Page, K., Lakshminarayanan, S., Allison, J., Wood, S., Semmel, D., Escolar, M.L., Martin, P.L., Carter, S. & Kurtzberg, J. (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood, 112, 29792989.
  • Ramírez, M., Regidor, C., Marugán, I., García-Conde, J., Bueren, J.A. & Fernández, M.N. (2005) Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice. Bone Marrow Transplantation, 35, 271275.
  • Rauser, G., Einsele, H., Sinzger, C., Wernet, D., Kuntz, G., Assenmacher, M., Campbell, J.D. & Topp, M.S. (2004) Rapid generation of combined CMVspecific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood, 103, 35653572.
  • Regidor, C., Krsnik, I., Forés, R., Cabrera, R., Bautista, G. & Fernandez, M.N. (2008) CD34+ and CFU data from post-thaw controls should be provided to transplant centres by the cord blood banks to facilitate selection of umbilical cord blood units for transplants. EBMT 2008 Annual Meeting Abstracts. Bone Marrow Transplant, 2008, 41 (abstract P593).
  • Rezvani, K., Mielke, S., Ahmadzadeh, M., Kilica, Y., Savani, B.N., Zeilah, J., Keyvanfar, K., Montero, A., Hensel, N., Kurlander, R. & Barrett, A.J. (2006) High donor FOXP3- positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood, 108, 12911297.
  • Rich, E., Artz, A., Karrison, T., Wickrema, A., Joseph, L., Godley, L., Odenike, O., Kline, J., Del Cerro, P., Cunningham, J., Larson, R., Stock, W. & Van Besien, K. (2008) Preliminary results of combined haploidentical-cord blood transplantation for patients lacking HLA identical donors. Blood (ASH Annual Meeting abstracts), 112, 3015.
  • Riddell, S.R., Bleakley, M., Nishida, T., Berger, C. & Warren, E.H. (2006) Adoptive transfer of allogeneic antigen-specific T cells. Biology of Blood and Marrow Transplantation, 12(Suppl. 1), 912.
  • Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L. & Le Blanc, K. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81, 13901397.
  • Robin, M., Schlageter, M.H., Chomienne, C. & Padua, R.A. (2005) Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans. Cancer Immunology and Immunotherapy, 54, 933943.
  • Rocha, V., Wagner, Jr, J.E., Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. & Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling: Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. New England Journal of Medicine, 342, 18461854.
  • Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. & Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 29622971.
  • Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., De Lima, M., Finke, J., Frassoni, F. & Gluckman, E.; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry (2004) Transplants of umbilical-cord blood or bonemarrow from unrelated donors in adults with acute leukemia. New England Journal of Medicine, 351, 22762285.
  • Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. & Stevens, C.E. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine, 339, 15651577.
  • Ruggeri, L., Mancusi, A., Perruccio, K., Burchielli, E., Martelli, M.F. & Velardi, A. (2005) Natural killer cell alloreactivity for leukaemia therapy. Journal of Immunotherapy, 28, 175182.
  • Sanz, M.A. (2004) Cord-blood transplantation in patients with leukemia—a real alternative for adults. New England Journal of Medicine, 351, 23282330.
  • Savoldo, B., Cubbage, M.L., Durett, A.G., Goss, J., Huls, M.H., Liu, Z., Teresita, L., Gee, A.P., Ling, P.D., Brenner, M.K., Heslop, H.E. & Rooney, C.M. (2002) Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. Journal of Immunology, 168, 909918.
  • Schoemans, H., Theunissen, K., Maertens, J., Boogaerts, M., Verfaillie, C. & Wagner, J. (2006) Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplantation, 38, 8393.
  • Schöttker, B., Feuchtinger, T., Schumm, M., Klinker, E., Handgretinger, R., Einsele, H. & Stuhler, G. (2008) Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nature Clinical Practice. Oncology, 2008, 5.
  • Shpall, E.J., Quinones, R., Giller, R., Zeng, C., Baron, A.E., Jones, R.B., Bearman, S.I., Nieto, Y., Freed, B., Madinger, N., Hogan, C.J., Slat-Vasquez, V., Russell, P., Blunk, B., Schissel, D., Hild, E., Malcolm, J., Ward, W. & McNiece, I.K. (2002) Transplantation of ex vivo expanded cord blood. Biology of Blood and Marrow Transplantation, 8, 368376.
  • Sudres, M., Norol, F., Trenado, A., Grégoire, S., Charlotte, F., Levacher, B., Lataillade, J.J., Bourin, P., Holy, X., Vernant, J.P., Klatzmann, D. & Cohen, J.L. (2006) Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. Journal of Immunology, 176, 77617767.
  • Sueblinvong, V., Suratt, B.T. & Weiss, D.J. (2007) Novel therapies for the treatment of cystic fibrosis: new developments in gene and stem cell therapy. Clinics in Chest Medicine, 28, 361379.
  • Szabolcs, P. & Niedzwiecki, D. (2007) Immune reconstitution after unrelated cord blood transplantation. Cytotherapy, 9, 111122.
  • Takahashi, S., Iseki, T., Ooi, J., Tomonari, A., Takasugi, K., Shimohakamada, Y., Yamada, T., Uchimaru, K., Tojo, A., Shirafuji, N., Kodo, H., Tani, K., Takahashi, T., Yamaguchi, T. & Asano, S. (2004) Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood, 104, 38133820.
  • Takahashi, S., Ooi, J., Tomonari, A., Konuma, T., Tsukada, N., Oiwa-Monna, M., Fukuno, K., Uchiyama, M., Takasugi, K., Iseki, T., Tojo, A., Yamaguchi, T. & Asano, S. (2007a) Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood, 109, 13221330.
  • Talvensaari, K., Clave, E., Douay, C., Rabian, C., Garderet, L., Busson, M., Garnier, F., Douek, D., Gluckman, E., Charron, D. & Toubert, A. (2002) A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood, 99, 14581464.
  • Tisato, V., Naresh, K., Girdlestone, J., Navarrete, C. & Dazzi, F. (2007) Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia, 21, 19921999.
  • Tse, W.W., Zang, S.L., Bunting, Kdan. & Laughlin, M.J. (2008) Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplantation, 41, 465472.
  • Vianello, F. & Dazzi, F. (2008) Mesenchymal stem cells for graft-versus-host disease: a double edged sword? Leukemia, 22, 463465.
  • Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. & Davies, S.M. (2002) Transplantation of unrelated donor umbilicalcord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 16111618.
  • Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D. & Riddell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. The New England Journal of Medicine, 333, 10381044.
  • Willemze, R., Rodrigues, C.A., Labopin, M., Sanz, G., Michel, G., Socié, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mohty, M., Ferra, C., Garnier, F., Loiseau, P., Garcia, J., Lecchi, L., Kögler, G., Beguin, Y., Navarrete, C., Devos, T., Ionescu, I., Boudjedir, K., Herr, A.L., Gluckman, E. & Rocha, V. (2009) KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia, 23, 630.